Virtual Zoom Meeting- Coping with your Lymphoma Diagnosis during COVID

A lymphoma diagnosis can be challenging to cope with at any time, and the current pandemic has only increased stress, anxiety, and depression for many lymphoma patients. To support the mental health and well-being of the lymphoma patient community, the Cutaneous Lymphoma Foundation, Lymphoma Research Foundation, and International Waldenstrom’s Macroglobulinemia Foundation have collaborated to offer a special session, Coping with Your Lymphoma Diagnosis During COVID.

The session will address the challenges of dealing with a lymphoma diagnosis with a special emphasis on the additional concerns of accessing treatment during a pandemic and managing anxiety and depression as a lymphoma patient. Coping with Your Lymphoma Diagnosis is designed as an interactive session, and will begin with a general overview of the topics followed by a Q&A discussion session.

Tammy Weitzman is a clinical social worker at the Seattle Cancer Care Alliance in Seattle, Washington. She has been a recognized leader in clinical social work for more than 19 years in the field of hematology/oncology and allogenic bone marrow transplantation. Her experience includes clinical care, program development and consultation, specifically as it pertains to lymphoma patients. She also has a special interest in working with patients living with graft versus host disease following allogenic transplantation.

This will be a Zoom meeting. Participants will be asked to turn on their cameras where possible during the session to improve the interactivity of the conversation. The presentation portion of the session will be recorded for future audiences, but any identifying participant information –including names, images, and voices –will be removed from the recording. If you would like to participate but have not used zoom, please contact Michelle at [email protected]

Eleven participants from the Lymphoma Research Foundation, Cutaneous Lymphoma Foundation and International Waldenstrom’s Macroglobulinemia Foundation have taken part in LLL with the following objectives:

• To create collaborative working relationships between organizations;

• To increase awareness of how strategic partnerships increase innovation and foster problem solving;

• To provide individualized skill building in productive conversations, program management, collaborative decision making and stakeholder management.

This session is funded through an unrestricted grant from Celgene Corporation, which was acquired in 2019 by Bristol-Myers Squibb.

Due to the interactive nature of the session, The IWMF is limited to 20 attendees to represent our organization. Register today!